Macquarie Group LTD Neoleukin Therapeutics, Inc. Transaction History

Macquarie Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$4.65 - $7.75 $55,614 - $92,690	-11,960 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.05 - $9.66 $69,224 - $110,529	11,442 Added 2208.88%	11,960 $86,000
Q1 2021 May 14, 2021	SELL	$11.26 - $15.78 $2,769 - $3,881	-246 Reduced 32.2%	518 $6,000
Q2 2020 Aug 11, 2020	SELL	$9.95 - $17.05 $47,829 - $81,959	-4,807 Reduced 86.29%	764 $13,000
Q1 2020 May 15, 2020	BUY	$6.12 - $13.64 $34,094 - $75,988	5,571 New	5,571 $63,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.